Skip to main content
Drimble New York

Biogen faces a crisis after failure of Alzheimer's drug

For the full story, click here. Biogen has been hit hard after the failure of its drug Aduhelm. The Massachusetts-based biotech company had high hopes in the first Alzheimer's trea…

More from New York City